NO914827D0 - Fremgangsmaate for fremstilling av heterocykliske aminer - Google Patents
Fremgangsmaate for fremstilling av heterocykliske aminerInfo
- Publication number
- NO914827D0 NO914827D0 NO1991914827A NO914827A NO914827D0 NO 914827 D0 NO914827 D0 NO 914827D0 NO 1991914827 A NO1991914827 A NO 1991914827A NO 914827 A NO914827 A NO 914827A NO 914827 D0 NO914827 D0 NO 914827D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- alkyl
- procedure
- preparation
- heterocyclic amines
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 abstract 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- YDVJBLJCSLVMSY-UHFFFAOYSA-N carbamoyl cyanide Chemical group NC(=O)C#N YDVJBLJCSLVMSY-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- -1 cyclic amine Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36437489A | 1989-06-09 | 1989-06-09 | |
| PCT/US1990/002621 WO1990015058A1 (en) | 1989-06-09 | 1990-05-15 | Heterocyclic amines having central nervous system activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO914827D0 true NO914827D0 (no) | 1991-12-06 |
| NO914827L NO914827L (no) | 1992-02-07 |
| NO301421B1 NO301421B1 (no) | 1997-10-27 |
Family
ID=23434241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO914827A NO301421B1 (no) | 1989-06-09 | 1991-12-06 | Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterocykliske aminer |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0480939B1 (no) |
| JP (1) | JP2955358B2 (no) |
| KR (1) | KR0167346B1 (no) |
| AT (1) | ATE117688T1 (no) |
| AU (1) | AU626427B2 (no) |
| CA (1) | CA2051697C (no) |
| DE (1) | DE69016430T2 (no) |
| DK (1) | DK0480939T3 (no) |
| ES (1) | ES2067744T3 (no) |
| FI (2) | FI96310C (no) |
| HK (1) | HK65397A (no) |
| HU (2) | HU210264B (no) |
| NO (1) | NO301421B1 (no) |
| RU (1) | RU2023712C1 (no) |
| WO (1) | WO1990015058A1 (no) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05117276A (ja) | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な３環性キノキサリンジオン誘導体 |
| TW260660B (no) * | 1993-04-22 | 1995-10-21 | Sumitomo Pharma | |
| DE4314593A1 (de) * | 1993-04-28 | 1994-11-03 | Schering Ag | Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln |
| USRE40278E1 (en) * | 1993-07-27 | 2008-04-29 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
| FR2719843B1 (fr) * | 1994-05-10 | 1996-06-07 | Synthelabo | Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique. |
| EP0705834A1 (de) * | 1994-07-27 | 1996-04-10 | Ciba-Geigy Ag | Azaaliphatisch Überbrückte Chinoxalin-2,3-dione |
| EP0705835A1 (de) * | 1994-09-01 | 1996-04-10 | Ciba-Geigy Ag | Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione |
| GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| JPH11514969A (ja) | 1995-08-10 | 1999-12-21 | バイエル・アクチエンゲゼルシヤフト | ハロベンゾイミダゾール類および殺微生物剤としてのそれらの使用 |
| FR2760237B1 (fr) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| US6288075B1 (en) | 1998-02-26 | 2001-09-11 | Rhone-Poulenc Rorer S.A. | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same |
| FR2766487B1 (fr) * | 1997-07-28 | 1999-08-27 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
| US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
| EP1149100A1 (en) | 1999-02-05 | 2001-10-31 | PHARMACIA & UPJOHN COMPANY | PROCESS TO PREPARE (5R)-(METHYLAMINO)-5,6-DIHYDRO-4H-IMIDAZO 4,5,1-ij]-QUINOLIN-2(1H)-ONE |
| US7074927B2 (en) | 1999-05-13 | 2006-07-11 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
| DE19954707A1 (de) * | 1999-11-13 | 2001-05-17 | Merck Patent Gmbh | Imidazolverbindungen als Phosphodiesterase VII-Hemmer |
| GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
| DK1274430T3 (da) * | 2000-04-21 | 2006-02-13 | Pharmacia & Upjohn Co Llc | Cabergolin til behandling af fibromyalgi og kronisk trathedssyndrom |
| AR033520A1 (es) * | 2000-04-27 | 2003-12-26 | Upjohn Co | (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona |
| MXPA03001472A (es) | 2000-08-16 | 2003-06-06 | Upjohn Co | Compuestos para el tratamiento de trastornos adictivos. |
| US6858604B2 (en) | 2000-11-03 | 2005-02-22 | Wyeth | Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| US6777407B2 (en) | 2000-11-03 | 2004-08-17 | Wyeth | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| AR031200A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados |
| WO2002067927A1 (en) * | 2001-02-27 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating psychotic disorders |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| TWI312781B (en) * | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
| TW200307682A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
| US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| US20050079217A1 (en) * | 2002-07-25 | 2005-04-14 | Ganorkar Loksidh D. | Sustained-release tablet composition comprising a dopamine receptor agonist |
| MY136318A (en) * | 2002-07-25 | 2008-09-30 | Pharmacia Corp | Sustained-release tablet composition |
| FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| PL376452A1 (en) * | 2002-10-25 | 2005-12-27 | Pharmacia & Upjohn Company Llc | Use of heterocyclic amine-type compounds as neuroprotective agents |
| US7262297B2 (en) * | 2003-05-15 | 2007-08-28 | Hoffmann-La Roche Inc. | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| JP2007500728A (ja) * | 2003-07-31 | 2007-01-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Ｐｄｆインヒビターとしての二環式化合物および組成物 |
| WO2005051488A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Combination of dopamine agonists and monoamine reuptake inhibitors |
| PT1789021E (pt) | 2004-08-13 | 2011-12-22 | Boehringer Ingelheim Int | Formulação de comprimidos de libertação prolongada contendo pramipexole ou um seu sal farmaceuticamente aceitável |
| UA97084C2 (ru) | 2004-08-13 | 2011-12-26 | Бьорингер Ингельхайм Интернациональ Гмбх | Пеллета пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, ее применение и капсула, которая содержит такие пеллеты |
| TW200635926A (en) * | 2004-11-05 | 2006-10-16 | Wyeth Corp | Metabolites of ceratin [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
| US7812013B2 (en) | 2005-06-14 | 2010-10-12 | Schering Corporation | Macrocyclic heterocyclic aspartyl protease inhibitors |
| AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
| US20140080813A1 (en) | 2012-09-14 | 2014-03-20 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
| UA116216C2 (uk) | 2012-09-14 | 2018-02-26 | Еббві Дойчланд Гмбх Унд Ко. Кг | Трициклічні хінолінові і хіноксалінові похідні |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3563389A (en) * | 1988-05-09 | 1989-11-29 | Upjohn Company, The | Anxiolytic/anti-depressant 2,3-dihydro-1h-phenalen-2-amines |
-
1990
- 1990-05-15 KR KR1019910701790A patent/KR0167346B1/ko not_active Expired - Fee Related
- 1990-05-15 AU AU57438/90A patent/AU626427B2/en not_active Ceased
- 1990-05-15 ES ES90908816T patent/ES2067744T3/es not_active Expired - Lifetime
- 1990-05-15 EP EP90908816A patent/EP0480939B1/en not_active Expired - Lifetime
- 1990-05-15 CA CA002051697A patent/CA2051697C/en not_active Expired - Fee Related
- 1990-05-15 WO PCT/US1990/002621 patent/WO1990015058A1/en not_active Ceased
- 1990-05-15 DK DK90908816.3T patent/DK0480939T3/da active
- 1990-05-15 HU HU905216A patent/HU210264B/hu not_active IP Right Cessation
- 1990-05-15 DE DE69016430T patent/DE69016430T2/de not_active Expired - Fee Related
- 1990-05-15 AT AT90908816T patent/ATE117688T1/de not_active IP Right Cessation
- 1990-05-15 JP JP2508489A patent/JP2955358B2/ja not_active Expired - Fee Related
-
1991
- 1991-12-04 FI FI915715A patent/FI96310C/fi active
- 1991-12-06 RU SU915010471A patent/RU2023712C1/ru not_active IP Right Cessation
- 1991-12-06 NO NO914827A patent/NO301421B1/no unknown
-
1994
- 1994-10-07 FI FI944704A patent/FI96687C/fi active
-
1995
- 1995-06-30 HU HU95P/P00660P patent/HU211702A9/hu unknown
-
1997
- 1997-05-15 HK HK65397A patent/HK65397A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04506071A (ja) | 1992-10-22 |
| FI96687B (fi) | 1996-04-30 |
| NO914827L (no) | 1992-02-07 |
| AU626427B2 (en) | 1992-07-30 |
| RU2023712C1 (ru) | 1994-11-30 |
| HUT60269A (en) | 1992-08-28 |
| JP2955358B2 (ja) | 1999-10-04 |
| CA2051697C (en) | 1996-10-08 |
| ATE117688T1 (de) | 1995-02-15 |
| EP0480939B1 (en) | 1995-01-25 |
| HU210264B (en) | 1995-03-28 |
| WO1990015058A1 (en) | 1990-12-13 |
| DK0480939T3 (da) | 1995-07-10 |
| FI944704A0 (fi) | 1994-10-07 |
| DE69016430T2 (de) | 1995-06-01 |
| FI944704L (fi) | 1994-10-07 |
| EP0480939A1 (en) | 1992-04-22 |
| FI96310B (fi) | 1996-02-29 |
| NO301421B1 (no) | 1997-10-27 |
| FI915715A0 (fi) | 1991-12-04 |
| KR920701204A (ko) | 1992-08-11 |
| HU905216D0 (en) | 1992-02-28 |
| DE69016430D1 (de) | 1995-03-09 |
| AU5743890A (en) | 1991-01-07 |
| HU211702A9 (en) | 1995-12-28 |
| FI96310C (fi) | 1996-06-10 |
| FI96687C (fi) | 1996-08-12 |
| ES2067744T3 (es) | 1995-04-01 |
| KR0167346B1 (ko) | 1999-01-15 |
| CA2051697A1 (en) | 1990-12-10 |
| HK65397A (en) | 1997-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO914827D0 (no) | Fremgangsmaate for fremstilling av heterocykliske aminer | |
| DE3681517D1 (de) | Thiazolidinderivate, verfahren zu deren herstellung und deren anwendung. | |
| FI102175B (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten v almistamiseksi | |
| BG104187A (en) | 4-phenyl-pyridine derivatives | |
| ATE86110T1 (de) | Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten. | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| FR2581063B1 (fr) | Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique | |
| BR0010693A (pt) | Derivados azaindol para tratamento de depressão | |
| DE69006452D1 (de) | Derivate und Analoge von Pyrimidon zur Behandlung von Asthma und bestimmte Hautkrankheiten. | |
| BG101220A (bg) | N-заместени 3-азабицикло(3.2.0) хептанови производни, метод за получаване и използването им | |
| DK492288D0 (da) | Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne | |
| KR900012893A (ko) | 치환된-아세트 아미드 화합물 및 그 제조방법 | |
| KR920701122A (ko) | 신규 이환식 아미노-치환 화합물 | |
| FR2618436B1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| PT885004E (pt) | Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmda | |
| ATE236634T1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen | |
| SE7605146L (sv) | Forfarande for framstellning av aminer | |
| DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
| ATE91077T1 (de) | Verwendung von cinnamamid-derivaten zur entspannung der muskeln. | |
| DE69327077D1 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
| KR910700236A (ko) | 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도 | |
| DE69010606D1 (de) | 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. | |
| PT85429A (en) | Process for the preparation of pharmaceutical compositions |